These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11532617)

  • 41. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients.
    Sportès C; McCarthy NJ; Hakim F; Steinberg SM; Liewehr DJ; Weng D; Kummar S; Gea-Banacloche J; Chow CK; Dean RM; Castro KM; Marchigiani D; Bishop MR; Fowler DH; Gress RE
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):472-83. PubMed ID: 15931636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
    Biron P; Durand M; Roché H; Delozier T; Battista C; Fargeot P; Spaeth D; Bachelot T; Poiget E; Monnot F; Tanguy ML; Curé H
    Bone Marrow Transplant; 2008 Mar; 41(6):555-62. PubMed ID: 18037940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy.
    Viret F; Chabannon C; Sainty D; Genre D; Gonçalves A; Arnoulet C; Gravis G; Bertucci F; Houvenaeghel G; Jacquemier J; Bardou VJ; Ladaique P; Braud AC; Maraninchi D; Viens P
    Bone Marrow Transplant; 2003 Dec; 32(11):1059-64. PubMed ID: 14625576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
    Kumar SK; Hayman SR; Kyle RA
    Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resolution of late-onset asthma following high-dose chemotherapy.
    Palmieri C; Gillmore R; Menzies-Gow A; Fishpool S; Robinson D; Shaw R; Coombes RC
    Bone Marrow Transplant; 2003 Oct; 32(8):847-8. PubMed ID: 14520433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
    Hale GA
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Phillips GL
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):53-6. PubMed ID: 12577245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.
    Kuzhan O; Ozet A; Ulutin C; Kurt B; Komurcu S; Ozturk B; Ataergin S; Gunhan O
    Saudi Med J; 2007 Sep; 28(9):1374-9. PubMed ID: 17768463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.
    Bishop MR; Fowler DH; Marchigiani D; Castro K; Kasten-Sportes C; Steinberg SM; Gea-Banacloche JC; Dean R; Chow CK; Carter C; Read EJ; Leitman S; Gress R
    J Clin Oncol; 2004 Oct; 22(19):3886-92. PubMed ID: 15314059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer trials--a new initiative.
    Br Med J; 1980 Dec; 281(6254):1565-6. PubMed ID: 7437881
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose chemotherapy and stem-cell support in breast cancer.
    Pedrazzoli P; Da Prada GA; Robustelli della Cuna G
    Lancet; 1998 Oct; 352(9135):1220. PubMed ID: 9777858
    [No Abstract]   [Full Text] [Related]  

  • 56. Challenges for future breast cancer trials.
    Lawrence G
    Oncology (Williston Park); 1996 Nov; 10(11):1610. PubMed ID: 8953582
    [No Abstract]   [Full Text] [Related]  

  • 57. Opinions divided on high-dose chemotherapy for breast cancer.
    Stephenson J
    JAMA; 1999 Jul; 282(2):119. PubMed ID: 10411179
    [No Abstract]   [Full Text] [Related]  

  • 58. High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future?
    Baynes RD; Dansey RD; Klein JL; Hamm C; Campbell M; Abella E; Peters WP
    Semin Oncol; 2001 Aug; 28(4):377-88. PubMed ID: 11498831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High dose chemotherapy and hematopoietic progenitor cell reinfusion in the treatment of solid tumors.
    Marangolo M
    Int J Artif Organs; 1999 Dec; 22(12):794-7. PubMed ID: 10654874
    [No Abstract]   [Full Text] [Related]  

  • 60. High-dose chemotherapy as adjuvant therapy in breast cancer: could there be a survival benefit?
    Moroni M
    J Clin Oncol; 2012 Mar; 30(7):759; author reply 759-60. PubMed ID: 22203770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.